Cutler Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,450
Closed -$746K 4918
2023
Q3
$746K Buy
6,450
+2,122
+49% +$228K 0.12% 310
2023
Q2
$445K Buy
4,328
+2,128
+97% +$225K 0.11% 364
2023
Q1
$240K Sell
2,200
-12,537
-85% -$1.39M 0.04% 608
2022
Q4
$1.68M Buy
+14,737
New +$1.22M 0.2% 153
2022
Q3
Sell
-300
Closed -$21K 6214
2022
Q2
$23K Sell
300
-30,069
-99% -$2.85M ﹤0.01% 2578
2022
Q1
$3.19M Buy
30,369
+21,474
+241% +$2.09M 0.3% 124
2021
Q4
$958K Sell
8,895
-3,911
-31% -$427K 0.07% 468
2021
Q3
$1.4M Buy
12,806
+11,511
+889% +$1.19M 0.11% 347
2021
Q2
$121K Buy
+1,295
New +$119K 0.01% 1712
2021
Q1
Sell
-12,133
Closed -$1.02M 7104
2020
Q4
$887K Buy
12,133
+3,833
+46% +$285K 0.07% 435
2020
Q3
$644K Buy
+8,300
New +$571K 0.07% 450
2019
Q4
Sell
-3,000
Closed -$81K 5513
2019
Q3
$81K Sell
3,000
-1,000
-25% -$25.9K 0.01% 1200
2019
Q2
$96K Sell
4,000
-500
-11% -$12.7K 0.01% 1122
2019
Q1
$118K Sell
4,500
-5,500
-55% -$130K 0.02% 922
2018
Q4
$195K Sell
10,000
-4,500
-31% -$88.2K 0.03% 652
2018
Q3
$283K Sell
14,500
-1,000
-6% -$19K 0.03% 686
2018
Q2
$256K Sell
15,500
-5,500
-26% -$83.9K 0.03% 679
2018
Q1
$298K Sell
21,000
-2,328
-10% -$34.4K 0.03% 622
2017
Q4
$340K Sell
23,328
-15,722
-40% -$221K 0.02% 702
2017
Q3
$495K Sell
39,050
-3,381
-8% -$43K 0.02% 665
2017
Q2
$503K Sell
42,431
-7,943
-16% -$98.8K 0.02% 689
2017
Q1
$744K Sell
50,374
-96,891
-66% -$1.57M 0.04% 497
2016
Q4
$2.38M Sell
147,265
-4,819
-3% -$87.4K 0.11% 177
2016
Q3
$2.76M Buy
152,084
+88,054
+138% +$1.72M 0.17% 124
2016
Q2
$1.05M Buy
64,030
+15,044
+31% +$243K 0.07% 281
2016
Q1
$811K Buy
48,986
+15,821
+48% +$277K 0.08% 327
2015
Q4
$718K Buy
+33,165
New +$646K 0.06% 458

Other funds holding HZNP